Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases

Stopped The study has closed earlier than planned due to one of the funders decision to withdraw the financial support for the study.

Conditions

• Neuroendocrine Tumor G1 (NET G1)/Carcinoid
• Neuroendocrine Tumor Grade 2
• Neuroendocrine Tumors
• Liver Metastases
• Gastroenteropancreatic Neuroendocrine Tumor
• Gastroenteropancreatic Neuroendocrine Neoplasm

Interventions

• DRUG: Lutathera

Sponsor

Imperial College London

Collaborators

• [object Object]
• [object Object]